Association between CLOCK, PER3 and CCRN4L with non‑small cell lung cancer in Brazilian patients

Couto,Patricia; Miranda,Debora; Vieira,Renalice; Vilhena,Alyne; De Marco,Luiz; Bastos‑Rodrigues,Luciana

doi:10.3892/mmr.2014.2224

Association between CLOCK, PER3 and CCRN4L with non‑small cell lung cancer in Brazilian patients

Authors:
- Patricia Couto
- Debora Miranda
- Renalice Vieira
- Alyne Vilhena
- Luiz De Marco
- Luciana Bastos‑Rodrigues
View Affiliations

Affiliations: Department of Surgery, Universidade Federal de Minas Gerais, Belo Horizonte, MG 30130‑100, Brazil, Department of Pediatrics, Universidade Federal de Minas Gerais, Belo Horizonte, MG 30130‑100, Brazil, Hospital Julia Kubitscheck, Belo Horizonte, MG 30620‑470, Brazil, Basic Department ‑ Health Area, Universidade Federal de Juiz de Fora, Campus Governador Valadares, Governador Valadares, MG 35010‑177, Brazil
Published online on: May 8, 2014 https://doi.org/10.3892/mmr.2014.2224
Pages: 435-440

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Circadian rhythms comprise of daily oscillations in a variety of biological processes and are regulated by an endogenous clock. Disruption of these rhythms has been associated with cancer progression, and understanding natural oscillations in cellular growth control, tumor suppression and cancer treatment, may reveal how clock and clock‑controlled genes are regulated in normal physiological functioning. To investigate the association between clock genes and non‑small cell lung cancer (NSCLC), we genotyped three tag SNPs (rs938836, rs17050680, rs3805213) in the Nocturnin gene (CCRN4L), five SNPs (rs228727, rs228644, rs228729, rs707467, rs104620202) in the period 3 (PER3) gene and one SNP (rs6855837) in the CLOCK gene, in 78 Brazilian patients with NSCLC. One tag SNP in CCRN4L (rs3805213) and another tag SNP from PER3 (rs228729) demonstrated a significant correlation with genotype and allele frequency in lung cancer (P=4.4x10‑3 and P=5.7x10‑2; P=0.004 and P=0.02, respectively). The results of our study suggest these polymorphisms in the CCRN4L and PER3 genes may represent a risk factor in the occurrence and development of NSCLC in Brazilian patients.

View Figures

View References

1	Filipski E and Lévi F: Circadian disruption in experimental cancer processes. Integr Cancer Ther. 8:298–302. 2009. View Article : Google Scholar : PubMed/NCBI
2	Alhopuro P, Bjorklund M, Sammalkorpi H, Turunen M, Tuupanen S, Biström M, Niittymäki I, Lehtonen HJ, Kivioja T, Launonen V, et al: Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res. 8:952–960. 2010. View Article : Google Scholar : PubMed/NCBI
3	Dibner C, Schibler U and Albrecht U: The mammalian circadian timing system: organization and coordination of central and peripheral clocks. Annu Rev Physiol. 72:517–549. 2010. View Article : Google Scholar : PubMed/NCBI
4	Wood PA, Yang X and Hrushesky WJ: Clock genes and cancer. Integr Cancer Ther. 8:303–308. 2009. View Article : Google Scholar
5	Karantanos T, Theodoropoulos G, Gazouli M, Vaiopoulou A, Karantanou C, Lymberi M and Pektasides D: Expression of clock genes in patients with colorectal cancer. Int J Biol Markers. 28:280–285. 2013. View Article : Google Scholar : PubMed/NCBI
6	Green C, Green CB, Douris N, Kojima S, Strayer CA, Fogerty J, Lourim D, Keller SR and Besharse JC: Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proc Natl Acad Sci USA. 104:9888–9893. 2007. View Article : Google Scholar : PubMed/NCBI
7	Lamont EW, James FO, Boivin DB and Cermakian N: From circadian clock gene expression to pathologies. Sleep Med. 8:547–556. 2007. View Article : Google Scholar : PubMed/NCBI
8	Richards J and Gumz ML: Advances in understanding the peripheral circadian clocks. FASEB J. 26:3602–3613. 2012. View Article : Google Scholar : PubMed/NCBI
9	Fu L and Lee CC: The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 3:350–361. 2003. View Article : Google Scholar : PubMed/NCBI
10	Hunt T and Sassone-Corsi P: Riding tandem: circadian clocks and the cell cycle. Cell. 129:461–464. 2007. View Article : Google Scholar : PubMed/NCBI
11	Green CB and Besharse JC: Identification of a novel vertebrate circadian clock-regulated gene encoding the protein nocturnin. Proc Natl Acad Sci USA. 93:14884–14888. 1996. View Article : Google Scholar : PubMed/NCBI
12	Bozek K, Relógio A, Kielbasa SM, Heine M, Dame C, Kramer A and Herzel H: Regulation of clock-controlled genes in mammals. PLoS ONE. 4:e48822009. View Article : Google Scholar : PubMed/NCBI
13	Parkin DM, Bray FI and Devesa SS: Cancer burden in the year 2000: The global picture. Eur J Cancer. 37(Suppl 8): S4–S66. 2001.PubMed/NCBI
14	Heist RS, Sequist LV and Engelman JA: Genetic changes in squamous cell lung cancer: a review. J Thorac Oncol. 7:924–933. 2012. View Article : Google Scholar : PubMed/NCBI
15	Miller SA, Dykes DD and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:12151988. View Article : Google Scholar : PubMed/NCBI
16	Lahiri DK and Nurnberger JI Jr: A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19:54441991. View Article : Google Scholar : PubMed/NCBI
17	Wang X, Yan D, Teng M, Fan J, Zhou C, Li D, Qiu G, Sun X, Li T, Xing T, et al: Reduced expression of PER3 is associated with incidence and development of colon cancer. Ann Surg Oncol. 19:3081–3088. 2012. View Article : Google Scholar : PubMed/NCBI
18	Climent J, Perez-Losada J, Quigley DA, Kim IJ, Delrosario R, Jen KY, Bosch A, Lluch A, Mao JH and Balmain A: Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer. J Clin Oncol. 28:3770–3778. 2010. View Article : Google Scholar : PubMed/NCBI
19	Zienolddiny S, Haugen A, Lie JA, Kjuus H, Anmarkrud KH and Kjærheim K: Analysis of polymorphisms in the circadian-related genes and breast cancer risk in the Norwegian nurses working night shifts. Breast Cancer Res. 15:R532013.(Epub ahead of print).
20	Zhu Y, Stevens RG, Hoffman AE, Fitzgerald LM, Kwon EM, Ostrander EA, Davis S, Zheng T and Stanford JL: Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study. Cancer Res. 69:9315–9322. 2009. View Article : Google Scholar : PubMed/NCBI
21	Zhou F, He X, Liu H, Zhu Y, Jin T, Chen C, Qu F, Li Y, Bao G, Chen Z and Xing J: Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer. Cancer. 118:937–946. 2012. View Article : Google Scholar
22	Zieker D, Jenne I, Koenigsrainer I, Zdichavsky M, Nieselt K, Buck K, Zieker J, Beckert S, Glatzle J, Spanagel R, et al: Circadian expression of clock- and tumor suppressor genes in human oral mucosa. Cell Physiol Biochem. 26:155–166. 2010. View Article : Google Scholar : PubMed/NCBI
23	Huang XL, Fu CJ and Bu RF: Role of circadian clocks in the development and therapeutics of cancer. J Int Med Res. 39:2061–2066. 2011. View Article : Google Scholar : PubMed/NCBI